Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas
一项随机、II期、双盲、实验性医学研究方案，比较奥妥珠单抗与利妥昔单抗治疗ANCA相关性血管炎的疗效：ObiVas
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-083277
McGovern, Dominic Paul; McClure, Mark E; Coates, Matthew; Bond, Simon; Martinez Del Pero, Marcos; Mynard, Kim; Lee, Jacinta; Smith, Rona M; Jayne, David R; Clatworthy, Menna Ruth; Jones, Rachel B
